These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 37501079)

  • 1. Super-enhancers complexes zoom in transcription in cancer.
    Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
    J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
    Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
    Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
    Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
    Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super enhancer lncRNAs: a novel hallmark in cancer.
    Song P; Han R; Yang F
    Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-enhancers and novel therapeutic targets in colorectal cancer.
    Liu Q; Guo L; Lou Z; Xiang X; Shao J
    Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
    Jia Q; Chen S; Tan Y; Li Y; Tang F
    Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The super-enhancer repertoire in porcine liver.
    Zhang Y; Zhang J; Wang C; Dai H; Du X; Li Q; Pan Z
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 36800318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of super enhancer in cancer].
    Wu ZQ; Mi ZY
    Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-enhancers: A new frontier for glioma treatment.
    Cheng M; Zhang ZW; Ji XH; Xu Y; Bian E; Zhao B
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188353. PubMed ID: 32112817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted regulation of enhancers in cancer.
    Xiao Q; Xiao Y; Li LY; Chen MK; Wu M
    Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194839. PubMed ID: 35750313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer RNAs: a missing regulatory layer in gene transcription.
    Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y
    Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.
    Hnisz D; Schuijers J; Lin CY; Weintraub AS; Abraham BJ; Lee TI; Bradner JE; Young RA
    Mol Cell; 2015 Apr; 58(2):362-70. PubMed ID: 25801169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-Enhancer-Driven Transcriptional Dependencies in Cancer.
    Sengupta S; George RE
    Trends Cancer; 2017 Apr; 3(4):269-281. PubMed ID: 28718439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
    Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
    J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
    Gen Y; Muramatsu T; Inoue J; Inazawa J
    Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
    Dębek S; Juszczyński P
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.
    Liu S; Dai W; Jin B; Jiang F; Huang H; Hou W; Lan J; Jin Y; Peng W; Pan J
    Mol Cancer; 2024 Jun; 23(1):122. PubMed ID: 38844984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.